Evidence map›Paper›PMID 29336923›Full record

ArticleVaccine2018

Report on WHO meeting on immunization in older adults: Geneva, Switzerland, 22-23 March 2017.

M Teresa Aguado, Jane Barratt, John R Beard, Bonnie B Blomberg, Wilbur H Chen, Julian Hickling, Terri B Hyde, Mark Jit, Rebecca Jones, Gregory A Poland and 2 more

Open access · hybridAbstract readConference Proceedings
In one paragraph

Article in Vaccine, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 33 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
33citing papers in PubMed, 1 pooled it
6.8field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

33 citing papers in PubMed, 1 synthesis or guideline pooled it, 65 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. A recent experience on the role of influenza vaccination on cardiovascular events.European heart journal supplements : journal of the European Society of Cardiology · 2023
    Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 7 institutions in 4 countries.

M Teresa AguadoVaccines and Immunization, Versoix, Switzerland. Electronic address: aguado.deros.t@gmail.com.
Jane BarrattInternational Federation on Ageing, Toronto, Canada. Electronic address: jbarratt@ifa-fiv.org.
John R BeardAgeing and Life Course, World Health Organization, Geneva, Switzerland. Electronic address: beardj@who.int.
Bonnie B BlombergDepartment of Microbiology and Immunology, University of Miami Miller School of Medicine, Miami, FL, USA. Electronic address: BBlomber@med.miami.edu.
Wilbur H ChenCenter for Vaccine Development, University of Maryland School of Medicine, Baltimore, MD, USA. Electronic address: wchen@som.umaryland.edu.
Julian HicklingWorking In Tandem Ltd, Cambridge, United Kingdom. Electronic address: julian@workingintandem.co.uk.
Terri B HydeVaccine Introduction Team, Global Immunization Division, Centers for Disease Control and Prevention, Atlanta, GA, USA. Electronic address: tkh4@cdc.gov.
Mark JitDepartment of Infectious Disease Epidemiology, London School of Hygiene & Tropical Medicine, United Kingdom; Modelling and Economics Unit, Public Health England, London, United Kingdom. Electronic address: mark.jit@lshtm.ac.uk.
Rebecca JonesWorking In Tandem Ltd, Cambridge, United Kingdom. Electronic address: rebecca@workingintandem.co.uk.
Gregory A PolandMayo Vaccine Research Group, Mayo Clinic and Foundation, Rochester, MN, USA. Electronic address: poland.gregory@mayo.edu.
Martin FriedeInitiative for Vaccine Research, World Health Organization, Geneva, Switzerland. Electronic address: friedem@who.int.
Justin R OrtizInitiative for Vaccine Research, World Health Organization, Geneva, Switzerland. Electronic address: influenzavaccine@who.int.
World Health Organization · CHInternational Federation on Ageing · CAMayo Clinic · USNational Center for Immunization and Respiratory Diseases · USPublic Health England · GBUniversity of Maryland, Baltimore · USUniversity of Miami · US

Funding

Enhanced collaboration between US NIH and WHO on biomedical researchU01AI108543 · NIAID · WORLD HEALTH ORGANIZATION · PI TROEDSSON, HANS · 2013 to 2018
$3.7M
Intramural CDC HHS CC999999NIAID NIH HHS U01 AI108543World Health Organization 001
6 · The paper itself

Abstract

Many industrialized countries have implemented routine immunization policies for older adults, but similar strategies have not been widely implemented in low- and middle-income countries (LMICs). In March 2017, the World Health Organization (WHO) convened a meeting to identify policies and activities to promote access to vaccination of older adults, specifically in LMICs. Participants included academic and industry researchers, funders, civil society organizations, implementers of global health interventions, and stakeholders from developing countries with adult immunization needs. These experts reviewed vaccine performance in older adults, the anticipated impact of adult vaccination programs, and the challenges and opportunities of building or strengthening an adult and older adult immunization platforms. Key conclusions of the meeting were that there is a need for discussion of new opportunities for vaccination of all adults as well as for vaccination of older adults, as reflected in the recent shift by WHO to a life-course approach to immunization; that immunization in adults should be viewed in the context of a much broader model based on an individual's abilities rather than chronological age; and that immunization beyond infancy is a global priority that can be successfully integrated with other interventions to promote healthy ageing. As WHO is looking ahead to a global Decade of Healthy Ageing starting in 2020, it will seek to define a roadmap for interdisciplinary collaborations to integrate immunization with improving access to preventive and other healthcare interventions for adults worldwide.

Indexed as

Immunization ProgramsVaccinationAgedAged, 80 and overAge FactorsAgingCommunicable Disease ControlGlobal HealthHumansVaccinesWorld Health OrganizationVaccinesAgeingGlobal healthImmune senescence, World Health OrganizationImmunizationVaccine development

Identifiers

PMID29336923
PMCPMC5865389
OpenAlexW2782592211

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.